1. Surber C, Schwarb FP, Smith EW. Tape-stripping technique. In: Bronaugh RL, Maibach HI, editors. Percutaneous absorption, vol. 97. 3rd ed. New York: Marcel Dekker; 1999. p. 395–409.
2. L. A. Nylander-French. Understanding dermal exposure - a critical step in exposure assessment. NIH, Research Brief. 2008;166.
3. Lademann J, Jacobi U, Surber C, Weigmann H-J, Fluhr JW. The tape stripping procedure—evaluation of some critical parameters. Eur J Pharm Biopharm. 2009;72(2):317–23.
4. Shah V. Topical drug products - regulatory requirements (USA). (2009). [Online]. Available from: https:// www.ipapharma.org/pdf/speaker/1.02%20Vinod%20Shah%20topical.pdf
5. Dotzel MM. Draft guidance for industry on topical dermatological drug product NDAs and ANDAs-in vivo bioavailability, bioequivalence, in vitro release and associated studies; withdrawal. U Fed Regist. 2002;67(96):35122–3.